Skip to content

Exploratory Study Using a New Head-only PET Scanner

Exploratory Study of BPET, an Investigational Medical Device Without CE-marking for PET Imaging of the Human Brain

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04511546
Acronym
ExploreBPET
Enrollment
10
Registered
2020-08-13
Start date
2020-10-27
Completion date
2021-03-05
Last updated
2021-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain Diseases

Brief summary

The BPET prototype is a small aperture PET scanner. The BPET prototype will be used with patients, which have just finished their regularly scheduled PET examination on a clinical whole body PET system. The radioactive tracer used for this procedure will still be active. This remaining acitivity will be used for an image acquisition with the BPET prototype without the need for an additional radioactive tracer dose. The control intervention is be a brain PET scan as part of standard clinical routine. It will be done immediately before the scan on the BPET prototype.

Interventions

DEVICEBPET Prototype Scan

Scan on the BPET Prototype PET system and qualitative comparison with a PET image acquired on a conventional clinical PET system.

Sponsors

University of Zurich
CollaboratorOTHER
Positrigo AG
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DEVICE_FEASIBILITY
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Capable of giving Informed Consent as documented by signature (Appendix Informed Consent Form) * ability to sit still in the head-only PET scanner for 15 minutes * Are scheduled to receive a regular brain PET scan as part of clinical routine. * Male and Female patients 18 years to 80 years of age

Exclusion criteria

* Contraindications to PET examination, * Patient height smaller than 160 cm or taller than 200 cm, * Patient weight more than 120 kg, * Patient cannot sit upright for at least 15 minutes, * Metal implants in the head, * Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, severe dementia, etc. of the participant, * Participation in another study with investigational drug/device within the 30 days preceding and during the present study, * Previous enrolment into the current study, * Enrolment of the investigator, his/her family members, employees and other dependent persons.

Design outcomes

Primary

MeasureTime frameDescription
PET image of the brain1 dayThe primary outcome will be a PET image of the brain for each participant taken on BPET. It will be compared against the image taken by the conventional PET machine by a trained physician and judged by whether it could be used for diagnosis and further analysis.

Secondary

MeasureTime frameDescription
Usability (patient feedback for seat comfort)1 dayThe secondary outcome with respect to usability will be feedback from patients with respect to patient seat comfort.
Usability (medical technologist feedback for ease of positioning)1 dayThe secondary outcome with respect to usability will be feedback from medical technologist with respect to easiness of patient positioning.

Other

MeasureTime frameDescription
Assessment of adverse eventsDuring the imaging procedure which should last 15 minutes.Safety of the procedure will be assessed by documenting adverse events (description of the adverse events, number of participants)
Assessment of device deficienciesDuring the imaging procedure which should last 15 minutes.Safety of the procedure will be assessed by documenting device deficiencies (description of the deficiency).
Identification of new risksDuring the imaging procedure which should last 15 minutes.Safety of the procedure will be assessed by identifying and documenting any new risk.

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026